Delivery Order SPE2DB20D2104-SPE2DB25FNBPK
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,477.57 for Lumigan 0.01% eye drops (7.5mL) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a single delivery of pharmaceutical products to support federal medical procurement needs. The work will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.12 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,374.22 to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (2.5 mL) on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $1,987.06 delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,470.15 on August 6, 2025, for the supply of Lumigan 0.01% eye drops in 5mL quantities. This non-set-aside contract employs firm fixed price terms with an ultimate completion date of August 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lumigan 0.01% eye drops in 5mL quantities under a firm fixed price contract. The award, issued on August 19, 2025, carries a ceiling value of $2,108.68 with an ultimate completion date of August 20, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a $2,121.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5ml), with an ultimate completion date of August 18, 2025. This contract represents a non-set-aside competitive award and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's...
- The Defense Logistics Agency awarded a $2,210.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lumigan 0.01% eye drops (5mL) on June 6, 2025, with an ultimate completion date of June 9, 2025. The order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- This federal contract award is for the delivery of Lumigan 0.01% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,130.27 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 20, 2024, with a completion date of February 21, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award is for the delivery of Lumigan 0.01% eye drops, 5 mL, to the Department of Defense (DoD) Medical Supply Chain (identified as the Defense Logistics Agency (DLA) Troop Support Medical). The contract, valued at $18,603.05, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 18, 2023, with a completion date of September 19, 2023. The contract is a firm-fixed-price delivery order and does not have a set-aside designation....
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBPKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Lumigan 0.01% Eye Drops (5mL) with a ceiling value of $1,173.24. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 26, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a wide range of medications, medical devices, and healthcare commodities to support military and federal healthcare systems worldwide. The IDC serves critical customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/25/25 |